All Stories

  1. Measles-vectored vaccine approaches against viral infections: a focus on chikungunya

    Article • Expert Review of Vaccines, January 2019, Taylor & Francis

    Dr Frederic Tangy

  2. Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.

    Article • OncoImmunology, December 2017, Taylor & Francis

    Nathalie Labarriere, Dr Frederic Tangy, Dr Jean-Francois Fonteneau, Mathieu Crupi

  3. Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response

    Article • Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals

    Dr Frederic Tangy

  4. Oncolytic virotherapy for human malignant mesothelioma: recent advances

    Article • Oncolytic Virotherapy, September 2015, Dove Medical Press

    Dr Frederic Tangy, Dr Jean-Francois Fonteneau

  5. Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro

    Article • Journal of Virology, January 2014, ASM Journals

    Dr Frederic Tangy

  6. Vaccines in Development against West Nile Virus

    Article • Viruses, September 2013, MDPI AG

    Dr Frederic Tangy

  7. Antitumor Virotherapy by Attenuated Measles Virus (MV)

    Article • Biology, March 2013, MDPI AG

    Dr Frederic Tangy, Dr Jean-Francois Fonteneau

  8. Efficacy of the anti-VZV (anti-HSV3) vaccine in HSV1 and HSV2 recurrent herpes simplex disease: a prospective study

    Article • Open Access Journal of Clinical Trials, July 2012, Dove Medical Press

    Dr Frederic Tangy, Dr Jacqueline Le Goaster